Saturday, October 31, 2026

South Korean Military: North Korea’s New Air Defense Missile Lacks THAAD-Level Interception Capability

U.S. analysts say North Korea's new surface-to-air missile lacks the capabilities of the THAAD system, despite claims of success.

Why You’re Always Cold and Tired—Signs of Hypothyroidism

Hypothyroidism can cause fatigue, weight gain, and sensitivity to cold. Early diagnosis and treatment are crucial for managing symptoms.

SK Hynix Targets 15 Trillion KRW with U.S. ADR Listing: What It Means for AI Semiconductor Dominance

SK Hynix plans to list ADRs in the U.S. to raise up to 15 trillion KRW, aiming to enhance its HBM production and market valuation.

News1

Author's Latest

How Digital Therapy for TMJ Disorders Transforms Patient Behavior: Key Findings from 2026 Study

Study shows digital therapy for temporomandibular disorders is linked to real changes in patient behavior, highlighting personalized treatment potential.

10 Years of Answers: Discover How Three Billion Transformed Rare Disease Testing

Three Billion, an AI-based rare disease genetic testing company, marks its 10th anniversary, serving over 100,000 patients globally.

Colombia Approves INNOVERSE Spinal System: What This Means for MedTech in Latin America

CG MedTech secures Colombian approval for spinal fixation systems, expanding its reach in the Latin American market.

Samsung Biologics Expands End-to-End CDMO Services: What This Means for Japan’s Biotech Market

We will respond to rapidly changing customer demands by providing end-to-end services encompassing CRO, CDO, and CMO.

Vieworks Unveils COF Integrated Solution With 100 Gbps Optical Data Transmission

Vieworks has unveiled an integrated CoaXPress-over-Fiber solution designed to meet growing demand for high-speed, high-resolution imaging in HBM and AI semiconductor inspection.

Lotte Biologics Signs Manufacturing Contract With Alvotech

Lotte Biologics has signed a manufacturing contract with Iceland-based biotech company Alvotech to produce multiple antibody biosimilar drug substances at its Syracuse, New York, facility for global supply.

Dong-A Reunites After 13 Years as Holding Company Brings Bacchus Business Back In-House

Dong-A Socio Holdings has absorbed its core operating subsidiary Dong-A Pharmaceutical, bringing Bacchus and other consumer healthcare businesses back under the holding company 13 years after the group separated its holding and operating entities.

Sillajen’s Two CEOs Aim to Redefine the Future With New Technologies

Sillajen is seeking to demonstrate a new phase of growth through its BAL0891 oncology candidate, SJ-600 oncolytic virus platform and stable pharmaceutical business.

K-Bio Companies Converge in Japan to Seek Global Partners

Major South Korean biotech companies are heading to BioJapan 2026 in Yokohama to pursue CDMO contracts, drug licensing deals and joint development opportunities across Japan and the broader Asia-Pacific market.

Unlocking Japan: How Wontech’s Velastar Laser Device Secured PMDA Certification

Wontech's laser medical device Velastar receives PMDA certification, enabling marketing and sales in Japan.

Celltrion Expands Appotuzma Approval to Treat Pediatric COVID-19: What This Means for Young Patients

Celltrion expands the U.S. approval of its biosimilar Actemra, Aptozma, to include pediatric COVID-19 patients.

Lirafugratinib: What the EMA’s Review Means for European Cancer Treatment in 2026

HLB announced that its U.S. subsidiary Elevar Therapeutics has begun the review process for the drug Liraglutide with EMA.

HLB’s Liver Cancer Drug Rivoseranib: FDA’s VAI Classification Sparks NDA Resubmission Plans

HLB's liver cancer drug manufacturing facility passed FDA inspection with Voluntary Action Indicated, speeding up NDA resubmission plans.

Ecnoglutide: The Breakthrough Obesity Treatment for Teens with Up to 12.6% BMI Reduction

HK Inno.N's obesity treatment Ecnoglutide shows up to 12.6% BMI and 12.1% weight reduction in clinical trial for obese adolescents.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.